Industry symposium - Argenx: The gMG treatment individualization evolution: Implications for your patients

12:00 • SYMP1L1 • Welcome and introduction > F. Francesco SACCÀ (Geneve) 12:10 • SYMP1L2 • Targeted treatments in gMG: Evolution of the treatment landscape and novel therapeutic targets > S. Suraj MULEY (Geneve, Switzerland) 12:25 • SYMP1L3 • Adapting the strategy: Working towards treatment individualization > F. Francesco SACCÀ (Geneve) 12:35 • SYMP1L4 • Panel discussion: Interactive case studies and practical implications for your patients 12:55 • SYMP1L5 • Q&A and close > F. Francesco SACCÀ (Geneve)